Astragaloside IV Alleviates Systemic Lupus Erythematosus by Modulating ITGB1/PTK2/p38 Pathway: Integrated Network Pharmacology and Experimental Validation

Zhongfu Tang, Lili Cheng, Ming Li, Chuanbing Huang Department of Rheumatology, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, People’s Republic of ChinaCorrespondence: Chuanbing Huang, Department of Rheumatology, The First Affiliated Hospital of Anhui Unive...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Tang Z, Cheng L, Li M, Huang C
Format:	Artigo
Język:	Inglês
Wydane:	Dove Medical Press 2025-10-01
Seria:	Drug Design, Development and Therapy
Hasła przedmiotowe:	Astragaloside IV systemic lupus erythematosus immune function inflammatory factors network pharmacology
Dostęp online:	https://www.dovepress.com/astragaloside-iv-alleviates-systemic-lupus-erythematosus-by-modulating-peer-reviewed-fulltext-article-DDDT
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!